Small Study Comparing Two Pain Medicines in Teenagers for Pain Control After Scoliosis Corrective Surgery.
Key facts
- Who runs it
- University of Malaya
- Where
- Malaysia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 114 people, planned
- Started
- 2 Feb 2026
- Expected to end
- 30 Jan 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Ketamine-Morphine PCA
- Morphine (Intravenous patient-controlled analgesia)
- Record updated
- 5 March 2026
Who can take part
- Age
- 10 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Aged > 10 years old
- Idiopathic scoliosis scheduled for single-stage posterior spinal fusion (PSF)
- American Society of Anaesthesiologists (ASA) physical status I-II
Who cannot take part
- Chronic opioid therapy or pre-operative pain > 3 months
- Concomitant monoamine-oxidase inhibitor or tricyclic antidepressant therapy
- Known hypersensitivity to morphine, ketamine or formulation excipients
- Uncontrolled asthma or severe restrictive lung disease
- Cardiac disease or clinically significant arrhythmia
- Epilepsy
- History of severe postoperative delirium
- Hepatic dysfunction (ALT or AST > 2 × upper limit of normal)
- Renal impairment (eGFR ≤ 60 mL min-¹ 1·73 m-²)
- Intellectual disability precluding PCA use
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to evaluate whether adding low-dose ketamine to PCA morphine reduces opioid requirements after posterior spinal fusion surgery in adolescent idiopathic scoliosis patients. Selected patients aged 10-18 years undergoing elective AIS surgery at University Malaya Medical Centre will be randomised to ketamine-morphine or morphine-only PCA. The primary outcome is cumulative morphine consumption at 48 hours, with secondary outcomes including pain scores, opioid-related adverse effects, time to ambulation, and patient satisfaction. This study aligns with national priorities for safe opioid stewardship and enhanced peri-operative care in Malaysia.
The 2 groups in the trial
- Ketamine-Morphine PCA (1:1 ratio)Treatment being tested
This group receives a ketamine-morphine PCA solution (1 mg mL-¹ + 1 mg mL-¹). This device deliver a 1 mL bolus, enforce a five-minute lock-out and cap delivery at 20 mL per four hours, with no background infusion. The patient will use PCA for at least 48 hours duration.
Treatment: Ketamine-Morphine PCA
- Morphine only PCAExisting treatment, for comparison
This group receives morphine alone PCA (1 mg mL-¹). This device deliver a 1 mL bolus, enforce a five-minute lock-out and cap delivery at 20 mL per four hours, with no background infusion. The patient will use PCA for at least 48 hours duration.
Treatment: Morphine (Intravenous patient-controlled analgesia)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Patient-Controlled Analgesia (PCA) With Ketamine-Morphine (PCA KetaMorph) vs PCA Morphine for Postoperative Analgesia in Idiopathic Scoliosis Surgery - A Randomized Controlled Trial
- Record updated
- 5 March 2026